JSM 2013 Home
Online Program Home
My Program

Abstract Details

Activity Number: 100
Type: Invited
Date/Time: Monday, August 5, 2013 : 8:30 AM to 10:20 AM
Sponsor: Section for Statistical Programmers and Analysts
Abstract - #310485
Title: Beyond SAS versus R: Making the Case for Open Source Software in Clinical Trials
Author(s): Kevin Buhr*+
Companies: University of Wisconsin
Keywords: drug development ; data analysis ; advantages of open source ; supporting data monitoring committees

In drug development, the case for using an open source system for a task is often made on the basis of a specific argument for the superiority of the particular system over the particular proprietary alternative for the particular task (e.g., R versus SAS for complex graphics) together with a general, defensive argument against perceived disadvantages of "open source in general". Where advantages of "open source in general" are mentioned, they are presented mostly abstractly. In this talk, I'll discuss some of the general attributes of open source projects (e.g., transparency, interoperability) that make them attractive for our industry and for reliable data and statistical analysis in particular, and I'll illustrate them with concrete examples taken from our group's work supporting data monitoring committees in interim monitoring of (mostly large, phase 3) drug trials.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2013 program

2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.